{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T18:14:15Z","timestamp":1775758455978,"version":"3.50.1"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2344,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1111\/j.1365-2133.2008.09004.x","type":"journal-article","created":{"date-parts":[[2009,1,13]],"date-time":"2009-01-13T16:01:15Z","timestamp":1231862475000},"page":"835-843","source":"Crossref","is-referenced-by-count":118,"title":["Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factors"],"prefix":"10.1093","volume":"160","author":[{"given":"C.","family":"Sunderk\u00f6tter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Herrgott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Br\u00fcckner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Moinzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ger\u00df","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Hunzelmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"B\u00f6hm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Krieg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"M\u00fcller-Ladner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Genth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Schulze-Lohoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Meurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Melchers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the DNSS Centers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Riemekasten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1111\/j.1365-2133.2008.09004.x-BIB1","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/1529-0131(199804)41:4<670::AID-ART14>3.0.CO;2-I","article-title":"Oral iloprost treatment in patients with Raynaud\u2019s phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study","volume":"41","author":"Wigley","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2008.09004.x-BIB2","first-page":"1","article-title":"Sample size calculations in scleroderma: a rational approach to choosing outcome measurements in scleroderma trials","volume":"18","author":"Pope","year":"1995","journal-title":"Clin Invest Med"},{"key":"10.1111\/j.1365-2133.2008.09004.x-BIB3","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/ard.60.6.585","article-title":"European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres","volume":"60","author":"Della Rossa","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2133.2008.09004.x-BIB4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.semarthrit.2007.05.003","article-title":"Incidence and prevalence of systemic sclerosis: a systematic literature review","volume":"37","author":"Chifflot","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2008.09004.x-BIB5","first-page":"215","article-title":"Digital ulcers in a cohort of 333 scleroderma patients","volume":"59","author":"Tiso","year":"2007","journal-title":"Reumatismo"},{"key":"10.1111\/j.1365-2133.2008.09004.x-BIB6","first-page":"2423","article-title":"Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study","volume":"34","author":"Hachulla","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1365-2133.2008.09004.x-BIB7","first-page":"1407","article-title":"Intravenous iloprost treatment of Raynaud\u2019s phenomenon and ischemic ulcers secondary to systemic sclerosis","volume":"19","author":"Wigley","year":"1992","journal-title":"J Rheumatol"},{"issue":"Suppl. 3","key":"10.1111\/j.1365-2133.2008.09004.x-BIB8","first-page":"iii49","article-title":"Vasoactive therapies in systemic sclerosis","volume":"45","author":"Riemekasten","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/j.1365-2133.2008.09004.x-BIB9","first-page":"503","article-title":"Effects of long-term cyclic iloprost therapy in systemic sclerosis with Raynaud\u2019s phenomenon. A randomized, controlled study","volume":"19","author":"Scorza","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"10.1111\/j.1365-2133.2008.09004.x-BIB10","first-page":"CD000953","article-title":"Iloprost and cisaprost for Raynaud\u2019s phenomenon in progressive systemic sclerosis","volume":"2","author":"Pope","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1365-2133.2008.09004.x-BIB11","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00105-006-1218-4","article-title":"Raynaud Ph\u00e4nomen in der Dermatologie. Teil 2: Therapie","volume":"57","author":"Sunderk\u00f6tter","year":"2006","journal-title":"Hautarzt"},{"key":"10.1111\/j.1365-2133.2008.09004.x-BIB12","first-page":"2440","article-title":"Severe refractory fingertip ulcerations in a patient with scleroderma: successful treatment with sildenafil","volume":"32","author":"Colglazier","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1365-2133.2008.09004.x-BIB13","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1002\/art.20676","article-title":"Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist","volume":"50","author":"Korn","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2008.09004.x-BIB14","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00296-008-0556-1","article-title":"Management of cutaneous vascular complications in systemic scleroderma: experience from the German network","volume":"28","author":"Herrgott","year":"2008","journal-title":"Rheumatol Int"},{"key":"10.1111\/j.1365-2133.2008.09004.x-BIB15","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/art.1780310207","article-title":"Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis","volume":"31","author":"Steen","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2008.09004.x-BIB16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-200203000-00004","article-title":"Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients","volume":"81","author":"Ferri","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/j.1365-2133.2008.09004.x-BIB17","first-page":"281","article-title":"Peripheral vasculopathy in patients with systemic sclerosis: difference in limited and diffuse subset of disease","volume":"31","author":"Ostojic","year":"2004","journal-title":"Clin Hemorheol Microcirc"},{"key":"10.1111\/j.1365-2133.2008.09004.x-BIB18","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/rheumatology\/ken179","article-title":"The registry of the German Network for Systemic Scleroderma: a nationwide database on frequency of disease subsets and patterns of organ involvement","volume":"47","author":"Hunzelmann","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/j.1365-2133.2008.09004.x-BIB19","first-page":"334","article-title":"Organ-specific diagnosis in patients with systemic sclerosis: recommendations of the German Network for Systemic Sclerosis (DNSS)","volume":"67","author":"Hunzelmann","year":"2008","journal-title":"Zeitschr Rheumatol"},{"key":"10.1111\/j.1365-2133.2008.09004.x-BIB20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0738-081X(94)90323-9","article-title":"Epidemiology of systemic sclerosis","volume":"12","author":"Medsger","year":"1994","journal-title":"Clin Dermatol"},{"key":"10.1111\/j.1365-2133.2008.09004.x-BIB21","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0363-5023(84)80216-6","article-title":"Management of sclerodermal finger ulcers","volume":"9","author":"Gahhos","year":"1984","journal-title":"J Hand Surg [Am]"},{"key":"10.1111\/j.1365-2133.2008.09004.x-BIB22","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/rheumatology\/36.8.889","article-title":"Six cases positive for anti-centromere antibodies with ulcer and gangrene in the extremities","volume":"36","author":"Takahashi","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1111\/j.1365-2133.2008.09004.x-BIB23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/ncprheum0115","article-title":"Mechanisms and consequences of fibrosis in systemic sclerosis","volume":"2","author":"Denton","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1111\/j.1365-2133.2008.09004.x-BIB24","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard.2006.062901","article-title":"Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database","volume":"66","author":"Walker","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"Suppl. 3","key":"10.1111\/j.1365-2133.2008.09004.x-BIB25","first-page":"iii33","article-title":"Pathophysiology and clinical consequences of Raynaud\u2019s phenomenon related to systemic sclerosis","volume":"45","author":"Sunderkotter","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/j.1365-2133.2008.09004.x-BIB26","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00105-006-1192-x","article-title":"Raynaud Ph\u00e4nomen in der Dermatologie. Teil 1: Pathophysiologie und Diagnostik","volume":"57","author":"Sunderk\u00f6tter","year":"2006","journal-title":"Hautarzt"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2008.09004.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2008.09004.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:44:01Z","timestamp":1676382241000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/160\/4\/835\/6641792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2008.09004.x","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}